32566-01-1 Usage
Description
2-(2-Aminophenyl)indole is an indole derivative that serves as a versatile amination reagent in organic synthesis. It is known for its ability to undergo condensation reactions with various reagents, leading to the formation of new and biologically active compounds.
Uses
Used in Pharmaceutical Industry:
2-(2-Aminophenyl)indole is used as a reactant in cascade reactions of benzopyranylidenemalonates with monoand dinucleophiles for the synthesis of complex organic molecules with potential pharmaceutical applications.
Used in Antimicrobial Agents Production:
2-(2-Aminophenyl)indole is used as a reactant for the preparation of mono-, bis-indolo[1,2-c]quinazolines, which exhibit antimicrobial properties and can be used in the development of new antibiotics.
Used in Antimalarial Agents Production:
2-(2-Aminophenyl)indole is used as a reactant in the synthesis of isocryptolepine alkaloid, which possesses antimalarial activity and can be utilized in the development of new treatments for malaria.
Used in Antitumor Agents Production:
2-(2-Aminophenyl)indole is used as a reactant for the preparation of cyanoindolo[3,2-c]quinolines and benzimidazo[1,2-c]quinazolines, which have antitumor properties and can be employed in the development of new cancer therapies.
General Description:
2-(2-Aminophenyl)indole is an indole derivative with a wide range of applications in the synthesis of biologically active compounds. Its ability to undergo condensation reactions with various reagents makes it a valuable amination reagent in organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 32566-01-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,5,6 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 32566-01:
(7*3)+(6*2)+(5*5)+(4*6)+(3*6)+(2*0)+(1*1)=101
101 % 10 = 1
So 32566-01-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H12N2/c15-12-7-3-2-6-11(12)14-9-10-5-1-4-8-13(10)16-14/h1-9,16H,15H2
32566-01-1Relevant articles and documents
New indolo[1,2-c]quinazolines for single-crystal field-effect transistor: A united experimental and theoretical studies
Puli, Venkat Swamy,Kilaru, Suresh,Bhongiri, Yadagiri,Marri, Sreenath Reddy,Tripathi, Anuj,Chetti, Prabhakar,Chatterjee, Anindita,Vukoti, Kiran Kumar,Pola, Someshwar
, (2021/08/30)
Here, we account the synthesis and characterization of a series of symmetrical fused heterocyclic aromatic hydrocarbons (HAHs) with an indolo[1,2-c]quinazoline (IQ) as the core moiety. All the new HAHs IQ series were systematically investigated by using various spectroscopic methods. Furthermore, their photo-physical properties were supported by density functional theory (DFT) and time-dependent density functional theory (TDDFT) studies to support the experimental findings. The tetramethyl-substituted indolo[1,2-c]quinazoline (TMIQ) compound is shown to exhibit the shifted type of π–π stacking interactions, which render this series as a new semiconducting material. Single-crystal-based field-effect transistor devices of TMIQ exhibited efficient charge transport behavior, giving a p-channel field-effect mobility of 0.25 cm2?V?1?s?1 with an on/off ratio of 5 × 105.
Selective CH or NH Imidoylative Annulation of 2-(2-Isocyanophenyl)-1H-indoles Leading to Diverse Indole-fused Scaffolds
Teng, Fan,Hu, Weiming,Hu, Huaanzi,Luo, Shuang,Zhu, Qiang
supporting information, p. 1414 - 1418 (2019/10/28)
2-(2-Isocyanophenyl)-1H-indoles, a class of functionalized isocyanides containing both aromatic CH and indolo NH functionalities, are first applied in selective imidoylative annulation reactions. Scaffolds of 6-aryl 11H-indolo[3,2-c]quinoline and 6-aryl i
HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
-
Paragraph 0187-0190; 0218-0221, (2019/05/29)
The present invention relates to a heterocyclic compound represented by chemical formula 1 and an organic light emitting device comprising the same. According to the present invention, the heterocyclic compound represented by the chemical formula 1 may be
